| 临床药师基于基因多态性和药物相互作用参与华法林个体化抗凝的临床实践 |
| |
| 引用本文： | 惠红岩,周祥,王学惠,邓智建.临床药师基于基因多态性和药物相互作用参与华法林个体化抗凝的临床实践[J].中国药事,2018,32(4):546-549. |
| |
| 作者姓名： | 惠红岩 周祥 王学惠 邓智建 |
| |
| 作者单位： | 新乡医学院第一附属医院, 卫辉 453100,新乡医学院第一附属医院, 卫辉 453100,新乡医学院第一附属医院, 卫辉 453100,新乡医学院第一附属医院, 卫辉 453100 |
| |
| 基金项目： | 河南省教育厅科学技术发展计划项目（编号142300410191） |
| |
| 摘 要： | 目的：探讨临床药师参与华法林个体化抗凝的临床实践。方法：参与1例INR频繁波动的华法林个体化给药的过程。结果：临床药师结合基因检测结果与药物相互作用原理，给出合并用药方案调整的建议，并对患者进行华法林用药教育。结论：基因多态性只是华法林个体化治疗过程中的部分影响因素，将其与环境因素有机结合起来，才能真正做到华法林的个体化抗凝治疗，提高抗凝治疗的成功率。
|
| 关 键 词： | 基因多态性 药物相互作用 华法林 个体化给药 |
| 收稿时间： | 2017/2/27 0:00:00 |
Clinical Practice of Individualized Anticoagulation of Warfarin by Clinical Pharmacists Based on Gene Polymorphism and Drug Interaction |
| |
| Hui Hongyan,Zhou Xiang,Wang Xuehui and Deng Zhijian.Clinical Practice of Individualized Anticoagulation of Warfarin by Clinical Pharmacists Based on Gene Polymorphism and Drug Interaction[J].Chinese Pharmaceutical Affairs,2018,32(4):546-549. |
| |
| Authors: | Hui Hongyan Zhou Xiang Wang Xuehui and Deng Zhijian |
| |
| Institution: | The First Affiliated Hospital of Xinxiang Medical University, Weihui 453100, China,The First Affiliated Hospital of Xinxiang Medical University, Weihui 453100, China,The First Affiliated Hospital of Xinxiang Medical University, Weihui 453100, China and The First Affiliated Hospital of Xinxiang Medical University, Weihui 453100, China |
| |
| Abstract: | Objective: To explore the clinical practice of individualized anticoagulation of Warfarin by clinical pharmacists. Methods: Clinical pharmacists participated in the process of individualized administration of Warfarin in 1 case with frequent fluctuation of INR. Results: The combined medication regimen was suggested and the patient was educated about the medication of Warfarin by clinical pharmacists based on gene testing results and principle of drug interaction. Conclusion: Gene polymorphism was only part of the influencing factors in the process of individualized medication of Warfarin. The combination of environmental factors with gene polymorphisms could truly achieve the individualized anticoagulation therapy and improve the success rate of anticoagulation therapy. |
| |
| Keywords: | gene polymorphism drug interaction Warfarin individualized medication |
|
| 点击此处可从《中国药事》浏览原始摘要信息 |
| 点击此处可从《中国药事》下载免费的PDF全文 |
